CFLAR and COVID-19: Our analysis of both SARS-CoV-2-infected hACE2 transgenic mice and autopsy samples from lung in COVID-19 patients demonstrated, for the first time, the in vivo overexpression of FLIP in myeloid cells in severe COVID-19 (Fig. 1).